Lv72
4859 积分 2021-07-15 加入
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
6天前
已完结
The Synthesis of SNAC Phenolate Salts and the Effect on Oral Bioavailability of Semaglutide
7天前
已完结
用UPLC-MS/MS法定量检测大鼠血浆中司美格鲁肽含量及其药代动力学研究
7天前
已完结
Lessons learned from QT prolongation risk assessment for antibody-drug conjugates in oncology
11天前
已完结
Development roadmap for subcutaneous delivery of high dose biologics - high concentration formulation, analytical comparability and patient preference considerations for large volume devices
11天前
已完结
Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
11天前
已完结
Considerations of non-human primate use in nonclinical toxicity study package for oncology therapeutics with well-characterized target in supports of 3Rs – an IQ DruSafe industry survey
11天前
已完结
Strategies to reduce the use of non-human primates in development of oncology ADCs with cytotoxic payloads
11天前
已完结
How useful are 3-month repeat-dose toxicology studies for the development of T cell engagers for oncology indications?
11天前
已完结
Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022)
11天前
已完结
皖公网安备34019202002308
